Liprolog Mix25 Kwikpen

Insulin lispro, the active ingredient in Liprolog Mix25 Kwikpen, is a rapid‑acting insulin analog presented as a pre‑filled KwikPen for subcutaneous use. It treats hyperglycemia in people with type 1 and type 2 diabetes mellitus and provides fast‑acting insulin to help control post‑prandial blood glucose levels.

GNH USA supplies Liprolog Mix25 Kwikpen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to Good Distribution Practice and offers regulatory‑compliant logistics.

Insulin lispro is a rapid‑acting insulin analog used to manage blood glucose in diabetes mellitus. - Type 1 diabetes mellitus: improves post‑prandial glucose control and reduces hyperglycaemic episodes. - Type 2 diabetes mellitus: assists in achieving glycaemic targets when combined with oral agents or basal insulin. - Gestational diabetes mellitus: provides rapid insulin coverage when diet and oral agents are insufficient.

Common Side Effects: - Hypoglycaemia: low blood glucose episodes, especially if meals are missed or delayed. - Injection site reactions: redness, swelling, or itching at the injection site. - Weight gain: modest increase due to improved glucose utilisation. - Lipodystrophy: localized changes in subcutaneous fat with repeated injections. - Localised allergic reactions: rash or urticaria at the site. - Nausea: occasional gastrointestinal discomfort.

Serious or Rare Side Effects: - Severe hypoglycaemia leading to seizures or loss of consciousness. - Anaphylactic reaction: difficulty breathing, swelling of face or throat. - Severe allergic reaction: widespread rash, hives, or angioedema. - Edema: abnormal fluid retention, particularly in the lower extremities. - Hypokalemia: low potassium levels, potentially causing cardiac arrhythmias. - Acute insulin allergy: systemic symptoms requiring immediate medical attention.

Before using Liprolog Mix25 Kwikpen, consider the following precautions: - Hypoglycaemia risk: monitor blood glucose closely and adjust meals or activity. - Dose adjustments: modify insulin dose when changing diet, exercise, or during illness. - Renal or hepatic impairment: use lower initial doses and monitor response. - Pregnancy and lactation: evaluate benefit‑risk ratio with a healthcare professional. - Allergic reactions: discontinue if signs of systemic hypersensitivity appear. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Insulin lispro may interact with several medicines that affect glucose levels.

Major Interactions (Avoid): - Sulfonylureas: additive hypoglycaemic effect. - Meglitinides: increased risk of severe hypoglycaemia. - Beta‑blockers: may mask hypoglycaemia symptoms. - Glucocorticoids: raise blood glucose, requiring dose increase. - Alcohol: potentiates hypoglycaemia, especially with fasting.

Moderate Interactions (Monitor Closely):\n- ACE inhibitors: may enhance insulin sensitivity, requiring dose review. - Thiazide diuretics: can increase blood glucose levels. - Antipsychotics: may cause weight gain and hyperglycaemia. - NSAIDs: affect renal function, influencing insulin clearance. - Thyroid hormones: alter metabolic rate, potentially affecting glucose control.